The tumor microenvironment is complex, comprising of extracellular matrix (ECM) components such as fibrin, elastin, laminin, collagen, platelet aggregation, etc. The ECM is known to obstruct the blood flow and perfusion to the tumor areas, limiting the effective delivery of drugs, contributing to inadequate drug response, and promoting drug resistance [108]. The gene discussed is ELN; the disease is neoplasm.